berberine has been researched along with Muscular Dystrophy, Facioscapulohumeral in 1 studies
Muscular Dystrophy, Facioscapulohumeral: An autosomal dominant degenerative muscle disease characterized by slowly progressive weakness of the muscles of the face, upper-arm, and shoulder girdle. The onset of symptoms usually occurs in the first or second decade of life. Affected individuals usually present with impairment of upper extremity elevation. This tends to be followed by facial weakness, primarily involving the orbicularis oris and orbicularis oculi muscles. (Neuromuscul Disord 1997;7(1):55-62; Adams et al., Principles of Neurology, 6th ed, p1420)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ciszewski, L | 1 |
| Lu-Nguyen, N | 1 |
| Slater, A | 1 |
| Brennan, A | 1 |
| Williams, HEL | 1 |
| Dickson, G | 1 |
| Searle, MS | 1 |
| Popplewell, L | 1 |
1 other study available for berberine and Muscular Dystrophy, Facioscapulohumeral
| Article | Year |
|---|---|
G-quadruplex ligands mediate downregulation of DUX4 expression.
Topics: Animals; Berberine; Cell Fusion; Cell Line, Tumor; Clone Cells; Down-Regulation; Enhancer Elements, | 2020 |